Filing Details

Accession Number:
0001209191-23-024724
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-18 19:09:19
Reporting Period:
2023-04-17
Accepted Time:
2023-04-18 19:09:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607678 Viking Therapeutics Inc. VKTX Pharmaceutical Preparations (2834) 461073877
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614578 Brian Lian C/O Viking Therapeutics, Inc.
9920 Pacific Heights Blvd, Suite 350
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Per Share Acquisiton 2023-04-17 125,000 $2.15 2,432,963 No 4 M Direct
Common Stock, Par Value $0.00001 Per Share Disposition 2023-04-17 155,000 $20.45 2,277,963 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-04-17 125,000 $0.00 125,000 $2.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-03-04 2026-03-04 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.
  2. 25% of the shares subject to the option vested on each anniversary of the grant date.